Monash IVF Group Limited
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MVF.AX | IDX.AX | ACL.AX | SAB.F | IQV | NTRA | |
|---|---|---|---|---|---|---|
| Market cap | 288.33M | 646.50M | 596.86M | 6.13B | 43.47B | 56.36B |
| P/E (TTM) | 37.0 | 28.8 | 26.7 | 17.1 | 32.1 | — |
| Forward P/E | 13.7 | 13.2 | 15.3 | — | 18.6 | -2,198.8 |
| Price/book | 1.2 | 1.0 | 4.0 | 1.2 | 6.5 | 30.8 |
| Dividend yield | 3.38% | 5.45% | 4.10% | 5.54% | — | — |
| 1-year change | +10.45% | −32.87% | +21.46% | +4.41% | +24.97% | +94.39% |
| Today | 0.00% | +1.47% | +0.95% | +0.08% | +0.46% | +0.62% |
The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 20 min.
Latest news
All MVF.AX news ›Former AustralianSuper CFO Matt Harrington joins Monash IVF
The news: Monash IVF has appointed Matt Harrington as its chief financial officer, effective 4 January 2027, succeeding interim CFO Birol Akdogan. The context: Harrington has over 20 years’ experience in senior finance and commercial…
Monash IVF Group Appoints Matt Harrington As Chief Financial Officer
TradingView Monash IVF Group Appoints Matt Harrington As Chief Financial Officer
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- capitalbrief.com1
- tradingview.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.